2024-03-27 12:26 | CC:CPH | Cipher Pharmaceuticals Inc | 9.50 | SEDAR Annual Information Form802 | SEDAR Annual Information Form |
2024-03-14 17:26 | CC:CPH | Cipher Pharmaceuticals Inc | 7.13 | SEDAR Audited Annual Financial Statements804 | SEDAR Audited Annual Financial Statements |
2024-03-14 17:26 | CC:CPH | Cipher Pharmaceuticals Inc | 7.13 | SEDAR MD & A815 | SEDAR MD & A |
2024-03-14 17:14 | CC:CPH | Cipher Pharmaceuticals Inc | 7.13 | News Release200 | Cipher Pharmaceuticals earns $20.38M (U.S.) in 2023 |
2024-03-08 09:28 | CC:CPH | Cipher Pharmaceuticals Inc | 7.29 | News Release200 | Cipher Pharmaceuticals to release 2023 results March 14 |
2024-02-15 09:09 | CC:CPH | Cipher Pharmaceuticals Inc | 7.37 | In the News525 | Globe says more upside than downside seen at Cipher |
2024-01-29 10:44 | CC:CPH | Cipher Pharmaceuticals Inc | 5.75 | News Release200 | Cipher Pharmaceuticals lists on OTCQX Best Market |
2023-11-24 17:09 | CC:CPH | Cipher Pharmaceuticals Inc | | News Release200 | Cipher Pharmaceuticals changes auditors to RSM Canada |
2023-11-15 17:08 | CC:CPH | Cipher Pharmaceuticals Inc | 5.42 | News Release200 | Cipher Pharma arranges NCIB to buy back up to 10% float |
2023-11-09 19:12 | CC:CPH | Cipher Pharmaceuticals Inc | 4.51 | Miscellaneous270 | Cipher Pharmaceuticals change in reporting status |
2023-11-09 17:57 | CC:CPH | Cipher Pharmaceuticals Inc | 4.51 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
2023-11-09 17:54 | CC:CPH | Cipher Pharmaceuticals Inc | 4.51 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2023-11-09 17:33 | CC:CPH | Cipher Pharmaceuticals Inc | 4.51 | News Release200 | Cipher earns $7.03-million (U.S.) in Q3 2023 |
2023-10-27 10:40 | CC:CPH | Cipher Pharmaceuticals Inc | 4.48 | News Release200 | Cipher Pharmaceuticals to release Q3 results Nov. 9 |
2023-10-12 13:30 | CC:CPH | Cipher Pharmaceuticals Inc | 4.28 | News Release200 | Cipher releases substantial issuer bid results |
2023-10-03 12:34 | CC:CPH | Cipher Pharmaceuticals Inc | 4.32 | News Release200 | Cipher reminds holders of substantial issuer bid expiry |
2023-09-07 16:48 | CC:CPH | Cipher Pharmaceuticals Inc | 4.39 | Miscellaneous270 | Cipher Pharmaceuticals share purchase offer |
2023-09-06 08:10 | CC:CPH | Cipher Pharmaceuticals Inc | 4.19 | SEDAR Issuer Bid Circular814 | SEDAR Issuer Bid Circular |
2023-09-05 14:13 | CC:CPH | Cipher Pharmaceuticals Inc | 3.97 | News Release200 | Cipher arranges $6-million substantial issuer bid |
2023-08-10 17:37 | CC:CPH | Cipher Pharmaceuticals Inc | 3.56 | News Release200 | Cipher Pharmaceuticals earns $3.07M (U.S.) in Q2 2023 |
2023-08-10 17:31 | CC:CPH | Cipher Pharmaceuticals Inc | 3.56 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2023-07-28 10:25 | CC:CPH | Cipher Pharmaceuticals Inc | 3.73 | News Release200 | Cipher Pharmaceuticals to release Q2 results Aug. 10 |
2023-07-05 09:55 | CC:CPH | Cipher Pharmaceuticals Inc | 3.57 | News Release200 | Cipher Pharma partner receives EU approval of MOB-015 |
2023-06-21 13:11 | CC:CPH | Cipher Pharmaceuticals Inc | 3.69 | News Release200 | Cipher Pharma shareholders approve all matters at ASM |
2023-06-02 08:16 | CC:CPH | Cipher Pharmaceuticals Inc | 3.91 | In the News525 | Globe says Cipher Pharma elevated to "speculative buy" |
2023-05-11 18:28 | CC:CPH | Cipher Pharmaceuticals Inc | 3.21 | News Release200 | Cipher earns $2.62-million (U.S.) in Q1 2023 |
2023-05-11 17:25 | CC:CPH | Cipher Pharmaceuticals Inc | 3.21 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2023-05-11 17:25 | CC:CPH | Cipher Pharmaceuticals Inc | 3.21 | SEDAR MD & A815 | SEDAR MD & A |
2023-05-04 17:54 | CC:CPH | Cipher Pharmaceuticals Inc | 3.28 | News Release200 | Cipher Pharmaceuticals to release Q1 results May 11 |